Breaking News Instant updates and real-time market news.

RDHL

RedHill Biopharma

$7.48 /

-0.35 (-4.47%)

08:55
09/08/20
09/08
08:55
09/08/20
08:55

RedHill Biopharma says opaganib demonstrates complete inhibition of SARS-CoV-2

RedHill Biopharma announced that opaganib demonstrated potent inhibition of SARS-CoV-2, the virus that causes COVID-19, achieving complete blockage of viral replication in an in vitro model of human lung bronchial tissue. Opaganib is a first-in-class, orally-administered, sphingosine kinase-2 selective inhibitor with dual anti-inflammatory and anti-viral activity that targets a host cell component, unaffected by viral mutation, thus minimizing the likelihood of resistance. Opaganib is currently being evaluated in global Phase 2/3 and U.S. Phase 2 clinical studies for the treatment of severe COVID-19 pneumonia. Working in collaboration with the University of Louisville Center for Predictive Medicine, opaganib was studied in a 3D tissue model of human bronchial epithelial cells which morphologically and functionally resembles the human airway and is similar to the model used to discover SARS-CoV-22. This study was designed to evaluate the in vitro efficacy of opaganib in inhibiting SARS-CoV-2 infection and included a positive control of remdesivir, a drug with known antiviral activity. Results from this study showed a clear and compelling antiviral effect of opaganib against SARS-CoV-2. Opaganib demonstrated the most potent activity compared to all compounds tested, including the positive control, remdesivir. Treatment of cells infected with SARS-CoV-2 resulted in a dose-dependent inhibition of virus production without compromising cell membrane integrity, a measure of cell viability and drug safety, further demonstrating opaganib's promising potential for treating patients with COVID-19. Opaganib at 1mg/ml completely inhibited viral replication as measured after three days of incubation. This potent opaganib activity compares favorably with remdesivir data as the active control in the RedHill study which is consistent with published remdesivir data3. Data from the study is planned to be submitted to a peer-reviewed journal. The ongoing global multi-center, randomized, double-blind, parallel-arm, placebo-controlled Phase 2/3 study evaluating opaganib for the treatment of patients with severe COVID-19 pneumonia continues to enroll with a target of up to 270 patients requiring hospitalization and treatment with supplemental oxygen. The study recently received approval in Israel and has been approved in the United Kingdom, Italy, Russia and Mexico, with further expansion progressing. In parallel, the randomized, double-blind, placebo-controlled U.S. Phase 2 study with opaganib in patients with severe COVID-19 pneumonia is more than 50% enrolled, with enrollment set to be completed in the coming weeks. Recently, a pre-scheduled independent Safety Monitoring Committee recommended that the study continue without change. The study, which is not powered for statistical significance, is set to enroll up to 40 patients requiring hospitalization and supplemental oxygen. The Company is in discussions with U.S. government agencies around potential funding to support the rapid advancement of opaganib toward potential emergency use approval. In addition to opaganib, RedHill's in-vitro study evaluated the antiviral activity of its Phase-2 stage investigational drug, RHB-107 serine protease inhibitor active against a number of human serine proteases, with results demonstrating potent inhibition of SARS-CoV-2 viral replication. A U.S. Phase 2/3 study with RHB-107 in an outpatient setting is planned to be initiated later this year. The results from the preclinical studies of opaganib and RHB-107 are preliminary and were provided to the Company by an independent third-party following an initial independent analysis and remain subject to additional review and analysis of the data and potentially supportive experiments.

  • 08

    Sep

  • 09

    Sep

  • 10

    Sep

  • 14

    Sep

RDHL RedHill Biopharma
$7.48 /

-0.35 (-4.47%)

08/14/20 Roth Capital
Roth Capital maintains Buy on RedHill after 'noisy' quarter
07/07/20 SMBC Nikko
RedHill Biopharma initiated with an Outperform at SMBC Nikko
02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Vertiv Holdings names Scott Cripps CAO » 16:15
10/01/20
10/01
16:15
10/01/20
16:15
VRT

Vertiv Holdings

$17.90 /

+0.59 (+3.41%)

Vertiv Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRT Vertiv Holdings
$17.90 /

+0.59 (+3.41%)

VRT Vertiv Holdings
$17.90 /

+0.59 (+3.41%)

09/08/20 Evercore ISI
Vertiv Holdings initiated with an Outperform at Evercore ISI
09/08/20 Evercore ISI
Vertiv Holdings initiated with an Outperform at Evercore ISI
08/20/20
Fly Intel: Top five analyst initiationsNewPage
08/20/20 BofA
Vertiv Holdings initiated with a Buy at BofA
VRT Vertiv Holdings
$17.90 /

+0.59 (+3.41%)

  • 13
    Aug
General news
Week of 9/30 Fed Balance Sheet to be released at 16:30  16:15
10/01/20
10/01
16:15
10/01/20
16:15
 
General news
Week of 9/21 Money Supply to be released at 16:30  16:15
10/01/20
10/01
16:15
10/01/20
16:15
 
Periodicals
Roblox working with investment banks for U.S. stock market listing, Reuters says » 16:14
10/01/20
10/01
16:14
10/01/20
16:14
ATVI

Activision Blizzard

$82.70 /

+1.78 (+2.20%)

, MSFT

Microsoft

$212.65 /

+2.35 (+1.12%)

, SNE

Sony

$76.52 /

-0.3 (-0.39%)

, TTWO

Take-Two

$166.03 /

+0.8 (+0.48%)

, GME

GameStop

$9.75 /

-0.455 (-4.46%)

, NTDOY

Nintendo

$0.00 /

+ (+0.00%)

, EA

Electronic Arts

$132.74 /

+2.35 (+1.80%)

, UBSFY

Ubisoft

$0.00 /

+ (+0.00%)

Video game platform…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$82.70 /

+1.78 (+2.20%)

MSFT Microsoft
$212.65 /

+2.35 (+1.12%)

SNE Sony
$76.52 /

-0.3 (-0.39%)

TTWO Take-Two
$166.03 /

+0.8 (+0.48%)

GME GameStop
$9.75 /

-0.455 (-4.46%)

NTDOY Nintendo
$0.00 /

+ (+0.00%)

EA Electronic Arts
$132.74 /

+2.35 (+1.80%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

ATVI Activision Blizzard
$82.70 /

+1.78 (+2.20%)

09/23/20 Baird
Demand for PS5, Xbox Series X continues to look 'strong,' says Baird
09/22/20 Jefferies
Microsoft deal for Bethesda underscores value of high-quality IP, says Jefferies
09/21/20 Baird
Bethesda deal 'checks a lot of boxes' for Microsoft, says Baird
09/17/20 Jefferies
Activision Blizzard price target bumped to $105 at Jefferies after gamer survey
MSFT Microsoft
$212.65 /

+2.35 (+1.12%)

07:58 Today Morgan Stanley
Azure partnership underscores Datadog's leading position, says Morgan Stanley
06:41 Today Mizuho
Datadog price target raised to $116 from $100 at Mizuho
09/29/20 Summit Insights
Mimecast downgraded to Hold from Buy at Summit Insights
09/29/20 Morgan Stanley
RingCentral price target raised to $300 from $280 at Morgan Stanley
SNE Sony
$76.52 /

-0.3 (-0.39%)

09/23/20 Baird
Demand for PS5, Xbox Series X continues to look 'strong,' says Baird
09/23/20 Loop Capital
GameStop price target raised to $9 from $6 at Loop Capital
09/21/20 Jefferies
Microsoft 'doubling down on gaming' with deal, says Jefferies
09/21/20 Cowen
Bethesda deal could alter competition between Microsoft and Sony, says Cowen
TTWO Take-Two
$166.03 /

+0.8 (+0.48%)

09/23/20 Baird
Demand for PS5, Xbox Series X continues to look 'strong,' says Baird
09/21/20 Baird
Bethesda deal 'checks a lot of boxes' for Microsoft, says Baird
09/17/20 Jefferies
Activision Blizzard price target bumped to $105 at Jefferies after gamer survey
08/04/20
Fly Intel: Top five analyst downgrades
GME GameStop
$9.75 /

-0.455 (-4.46%)

09/23/20 Baird
Demand for PS5, Xbox Series X continues to look 'strong,' says Baird
09/23/20 Loop Capital
GameStop price target raised to $9 from $6 at Loop Capital
09/14/20
Fly Intel: Top five analyst upgrades
09/14/20 Jefferies
GameStop upgraded to Buy ahead of video game console cycle at Jefferies
NTDOY Nintendo
$0.00 /

+ (+0.00%)

09/10/20 Jefferies
Nintendo upgraded to Buy on WFH boost at Jefferies
09/10/20 Jefferies
Nintendo upgraded to Buy from Hold at Jefferies
08/20/20 Craig-Hallum
Nvidia price target raised to $480 from $335 at Craig-Hallum
07/29/20 Goldman Sachs
Nintendo resumed with a Buy at Goldman Sachs
EA Electronic Arts
$132.74 /

+2.35 (+1.80%)

09/30/20 Baird
Electronic Arts estimates raised but still below consensus, says Baird
09/23/20 Baird
Demand for PS5, Xbox Series X continues to look 'strong,' says Baird
09/22/20 Jefferies
Microsoft deal for Bethesda underscores value of high-quality IP, says Jefferies
09/21/20 Baird
Bethesda deal 'checks a lot of boxes' for Microsoft, says Baird
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

09/15/20 Citi
Citi opens '90-day Positive Catalyst Watch' on Ubisoft
09/11/20 JPMorgan
Ubisoft Overweight rating affirmed at JPMorgan after Forward event
09/11/20 Jefferies
Ubisoft upgraded to Buy from Hold at Jefferies
07/23/20 JPMorgan
Ubisoft price target raised to EUR 82 from EUR 79 at JPMorgan
ATVI Activision Blizzard
$82.70 /

+1.78 (+2.20%)

MSFT Microsoft
$212.65 /

+2.35 (+1.12%)

SNE Sony
$76.52 /

-0.3 (-0.39%)

TTWO Take-Two
$166.03 /

+0.8 (+0.48%)

GME GameStop
$9.75 /

-0.455 (-4.46%)

NTDOY Nintendo
$0.00 /

+ (+0.00%)

EA Electronic Arts
$132.74 /

+2.35 (+1.80%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

ATVI Activision Blizzard
$82.70 /

+1.78 (+2.20%)

MSFT Microsoft
$212.65 /

+2.35 (+1.12%)

SNE Sony
$76.52 /

-0.3 (-0.39%)

TTWO Take-Two
$166.03 /

+0.8 (+0.48%)

GME GameStop
$9.75 /

-0.455 (-4.46%)

NTDOY Nintendo
$0.00 /

+ (+0.00%)

EA Electronic Arts
$132.74 /

+2.35 (+1.80%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

ATVI Activision Blizzard
$82.70 /

+1.78 (+2.20%)

MSFT Microsoft
$212.65 /

+2.35 (+1.12%)

SNE Sony
$76.52 /

-0.3 (-0.39%)

TTWO Take-Two
$166.03 /

+0.8 (+0.48%)

GME GameStop
$9.75 /

-0.455 (-4.46%)

NTDOY Nintendo
$0.00 /

+ (+0.00%)

EA Electronic Arts
$132.74 /

+2.35 (+1.80%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

ATVI Activision Blizzard
$82.70 /

+1.78 (+2.20%)

MSFT Microsoft
$212.65 /

+2.35 (+1.12%)

SNE Sony
$76.52 /

-0.3 (-0.39%)

TTWO Take-Two
$166.03 /

+0.8 (+0.48%)

GME GameStop
$9.75 /

-0.455 (-4.46%)

EA Electronic Arts
$132.74 /

+2.35 (+1.80%)

MSFT Microsoft
$212.65 /

+2.35 (+1.12%)

Initiation
TechnipFMC initiated with a Market Perform at BMO Capital » 16:13
10/01/20
10/01
16:13
10/01/20
16:13
FTI

TechnipFMC

$6.27 /

-0.04 (-0.63%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTI TechnipFMC
$6.27 /

-0.04 (-0.63%)

FTI TechnipFMC
$6.27 /

-0.04 (-0.63%)

08/07/20 HSBC
TechnipFMC downgraded to Hold from Buy at HSBC
08/07/20 HSBC
TechnipFMC downgraded to Hold from Buy at HSBC
07/01/20 Tudor Pickering
TechnipFMC upgraded to Buy from Hold at Tudor Pickering
05/26/20 UBS
TechnipFMC price target raised to EUR 9.30 from EUR 8.50 at UBS
FTI TechnipFMC
$6.27 /

-0.04 (-0.63%)

FTI TechnipFMC
$6.27 /

-0.04 (-0.63%)

FTI TechnipFMC
$6.27 /

-0.04 (-0.63%)

Initiation
Evofem initiated with a Buy at Stifel » 16:13
10/01/20
10/01
16:13
10/01/20
16:13
EVFM

Evofem

$2.39 /

+0.035 (+1.49%)

Stifel analyst Annabel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVFM Evofem
$2.39 /

+0.035 (+1.49%)

EVFM Evofem
$2.39 /

+0.035 (+1.49%)

08/20/20 Morgan Stanley
Evofem initiated with an Equal Weight at Morgan Stanley
08/20/20 Morgan Stanley
Evofem initiated with an Equal Weight at Morgan Stanley
08/10/20 Oppenheimer
Evofem price target raised to $25 from $18 at Oppenheimer
06/09/20 H.C. Wainwright
Evofem price target lowered to $9 from $11 at H.C. Wainwright
EVFM Evofem
$2.39 /

+0.035 (+1.49%)

  • 03
    Jun
EVFM Evofem
$2.39 /

+0.035 (+1.49%)

EVFM Evofem
$2.39 /

+0.035 (+1.49%)

Initiation
National Oilwell initiated with an Underperform at BMO Capital » 16:12
10/01/20
10/01
16:12
10/01/20
16:12
NOV

National Oilwell

$8.64 /

-0.425 (-4.69%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NOV National Oilwell
$8.64 /

-0.425 (-4.69%)

NOV National Oilwell
$8.64 /

-0.425 (-4.69%)

05/14/20 Barclays
National Oilwell downgraded to Equal Weight on valuation at Barclays
05/14/20 Barclays
National Oilwell downgraded to Equal Weight from Overweight at Barclays
04/14/20 Cowen
National Oilwell upgraded to Outperform at Cowen
04/14/20 Cowen
National Oilwell upgraded to Outperform from Market Perform at Cowen
NOV National Oilwell
$8.64 /

-0.425 (-4.69%)

NOV National Oilwell
$8.64 /

-0.425 (-4.69%)

Hot Stocks
Delcath Systems appoints Gerard Michel as CEO, John Purpura as COO » 16:12
10/01/20
10/01
16:12
10/01/20
16:12
DCTH

Delcath Systems

$11.79 /

+0.19 (+1.64%)

, VCEL

Vericel

$19.55 /

+1.02 (+5.50%)

Delcath Systems (DCTH)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DCTH Delcath Systems
$11.79 /

+0.19 (+1.64%)

VCEL Vericel
$19.55 /

+1.02 (+5.50%)

DCTH Delcath Systems
$11.79 /

+0.19 (+1.64%)

06/04/20
Fly Intel: Top five analyst initiations
06/04/20 Roth Capital
Delcath Systems initiated with a Buy at Roth Capital
06/01/20 Laidlaw
Delcath Systems initiated with a Buy at Laidlaw
VCEL Vericel
$19.55 /

+1.02 (+5.50%)

09/23/20 BTIG
Vericel price target raised to $23 from $21 at BTIG
09/16/20 Truist
Vericel initiated with a Buy at Truist
05/06/20 Ladenburg
Vericel price target raised to $22 from $20 at Ladenburg
04/20/20 Oppenheimer
Avita Medical initiated with an Outperform at Oppenheimer
DCTH Delcath Systems
$11.79 /

+0.19 (+1.64%)

VCEL Vericel
$19.55 /

+1.02 (+5.50%)

Hot Stocks
SP Plus commences with plan to install new 'touchless' equipment at LRD » 16:12
10/01/20
10/01
16:12
10/01/20
16:12
SP

SP Plus

$18.17 /

+0.19 (+1.06%)

SP Plus announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SP SP Plus
$18.17 /

+0.19 (+1.06%)

SP SP Plus
$18.17 /

+0.19 (+1.06%)

05/11/20 Barrington
SP Plus price target lowered to $36 from $51 at Barrington
01/07/20 Barrington
Adtalem, Tivity, Virtusa among Barrington's Best Ideas for 2020
11/06/19 Barrington
SP Plus price target raised to $51 from $43 at Barrington
SP SP Plus
$18.17 /

+0.19 (+1.06%)

Initiation
Baker Hughes initiated with a Market Perform at BMO Capital » 16:11
10/01/20
10/01
16:11
10/01/20
16:11
BKR

Baker Hughes

$12.74 /

-0.54 (-4.07%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKR Baker Hughes
$12.74 /

-0.54 (-4.07%)

BKR Baker Hughes
$12.74 /

-0.54 (-4.07%)

08/13/20
Fly Intel: Top five analyst downgrades
08/13/20 Goldman Sachs
Baker Hughes downgraded to Buy from Conviction Buy at Goldman Sachs
07/23/20 Susquehanna
Baker Hughes price target raised to $22 from $19 at Susquehanna
07/16/20 Scotiabank
Baker Hughes downgraded to Sector Perform from Outperform at Scotiabank
BKR Baker Hughes
$12.74 /

-0.54 (-4.07%)

BKR Baker Hughes
$12.74 /

-0.54 (-4.07%)

Initiation
Halliburton initiated with a Market Perform at BMO Capital » 16:10
10/01/20
10/01
16:10
10/01/20
16:10
HAL

Halliburton

$11.14 /

-0.925 (-7.67%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAL Halliburton
$11.14 /

-0.925 (-7.67%)

HAL Halliburton
$11.14 /

-0.925 (-7.67%)

08/13/20
Fly Intel: Top five analyst upgrades
08/13/20 Goldman Sachs
Halliburton upgraded to Conviction Buy from Buy at Goldman Sachs
07/22/20 HSBC
Halliburton price target raised to $13.70 from $9.50 at HSBC
07/21/20
Fly Intel: Top five analyst upgrades
HAL Halliburton
$11.14 /

-0.925 (-7.67%)

HAL Halliburton
$11.14 /

-0.925 (-7.67%)

HAL Halliburton
$11.14 /

-0.925 (-7.67%)

HAL Halliburton
$11.14 /

-0.925 (-7.67%)

Initiation
Schlumberger initiated with an Outperform at BMO Capital » 16:09
10/01/20
10/01
16:09
10/01/20
16:09
SLB

Schlumberger

/

+

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLB Schlumberger
/

+

SLB Schlumberger
/

+

08/13/20
Fly Intel: Top five analyst upgrades
08/13/20 Wells Fargo
Schlumberger upgraded to Overweight at Wells Fargo
08/13/20 Wells Fargo
Schlumberger upgraded to Overweight from Equal Weight at Wells Fargo
07/27/20 Citi
Schlumberger upgraded to Buy from Neutral at Citi
SLB Schlumberger
/

+

SLB Schlumberger
/

+

SLB Schlumberger
/

+

SLB Schlumberger
/

+

Initiation
TransAlta Renewables initiated with a Neutral at Credit Suisse » 16:09
10/01/20
10/01
16:09
10/01/20
16:09
TRSWF

TransAlta Renewables

$0.00 /

+ (+0.00%)

Credit Suisse initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRSWF TransAlta Renewables
$0.00 /

+ (+0.00%)

08/04/20 CIBC
TransAlta Renewables price target raised to C$16 from C$15.50 at CIBC
07/29/20 Raymond James
TransAlta Renewables downgraded to Market Perform at Raymond James
06/04/20 National Bank
TransAlta Renewables C$17.50 price target maintained at National Bank
03/31/20 TD Securities
TransAlta Renewables upgraded to Buy from Hold at TD Securities
Hot Stocks
ICF International awarded $25M contract with Department of Health » 16:08
10/01/20
10/01
16:08
10/01/20
16:08
ICFI

ICF International

$61.71 /

+0.11 (+0.18%)

ICF was recently awarded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ICFI ICF International
$61.71 /

+0.11 (+0.18%)

ICFI ICF International
$61.71 /

+0.11 (+0.18%)

07/01/20 Berenberg
ICF International upgraded to Buy from Hold at Berenberg
05/18/20 Canaccord
ICF International price target lowered to $80 from $88 at Canaccord
01/15/20 Barrington
ICF International price target raised to $104 from $98 at Barrington
12/19/19 Canaccord
ICF International initiated with a Buy at Canaccord
ICFI ICF International
$61.71 /

+0.11 (+0.18%)

Hot Stocks
UFP Industries acquires Fire Retardant Chemical Technologies » 16:08
10/01/20
10/01
16:08
10/01/20
16:08
UFPI

UFP Industries

$56.97 /

+0.43 (+0.76%)

UFP Industries announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UFPI UFP Industries
$56.97 /

+0.43 (+0.76%)

UFPI UFP Industries
$56.97 /

+0.43 (+0.76%)

07/27/20 BMO Capital
UFP Industries price target raised to $53 from $44 at BMO Capital
06/18/20 Benchmark
UFP Industries price target raised to $56 from $50 at Benchmark
04/23/20 Wedbush
UFP Industries price target lowered to $40 from $58 at Wedbush
03/11/20
Fly Intel: Top five analyst initiations
UFPI UFP Industries
$56.97 /

+0.43 (+0.76%)

Initiation
Papa John's initiated with a Buy at Loop Capital » 16:07
10/01/20
10/01
16:07
10/01/20
16:07
PZZA

Papa John's

$83.20 /

+0.87 (+1.06%)

Loop Capital initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PZZA Papa John's
$83.20 /

+0.87 (+1.06%)

PZZA Papa John's
$83.20 /

+0.87 (+1.06%)

06:11 Today KeyBanc
Papa John's initiated with an Overweight at KeyBanc
08/25/20 Stephens
Papa John's August results 'a positive surprise,' says Stephens
08/07/20 CL King
Papa John's price target raised to $110 from $90 at CL King
08/07/20 Stephens
Papa John's price target raised to $108 from $94 at Stephens
PZZA Papa John's
$83.20 /

+0.87 (+1.06%)

PZZA Papa John's
$83.20 /

+0.87 (+1.06%)

PZZA Papa John's
$83.20 /

+0.87 (+1.06%)

Initiation
Shake Shack initiated with a Buy at Loop Capital » 16:07
10/01/20
10/01
16:07
10/01/20
16:07
SHAK

Shake Shack

$64.79 /

+0.3 (+0.47%)

Loop Capital initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHAK Shake Shack
$64.79 /

+0.3 (+0.47%)

SHAK Shake Shack
$64.79 /

+0.3 (+0.47%)

09/22/20 Truist
Shake Shack price target raised to $58 from $51 at Truist
09/14/20 Piper Sandler
Shake Shack price target raised to $78 from $60 at Piper Sandler
08/20/20
Fly Intel: Top five analyst upgrades
08/20/20 Wedbush
Wedbush upgrades Shake Shack on 'even more attractive' post-COVID position
SHAK Shake Shack
$64.79 /

+0.3 (+0.47%)

SHAK Shake Shack
$64.79 /

+0.3 (+0.47%)

SHAK Shake Shack
$64.79 /

+0.3 (+0.47%)

SHAK Shake Shack
$64.79 /

+0.3 (+0.47%)

Earnings
Smart Global sees Q1 EPS 70c +/- 5c, consensus 68c » 16:07
10/01/20
10/01
16:07
10/01/20
16:07
SGH

Smart Global

$28.11 /

+0.76 (+2.78%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGH Smart Global
$28.11 /

+0.76 (+2.78%)

SGH Smart Global
$28.11 /

+0.76 (+2.78%)

06/05/20 Rosenblatt
Rosenblatt starts 'misunderstood' Smart Global at Buy
06/05/20 Rosenblatt
Smart Global initiated with a Buy at Rosenblatt
04/17/20 Barclays
Smart Global downgraded to Equal Weight on Brazil exposure at Barclays
04/17/20 Barclays
Smart Global downgraded to Equal Weight from Overweight at Barclays
SGH Smart Global
$28.11 /

+0.76 (+2.78%)

SGH Smart Global
$28.11 /

+0.76 (+2.78%)

SGH Smart Global
$28.11 /

+0.76 (+2.78%)

Syndicate
Golden Minerals files to sell 11.25M shares of common stock for holders  16:06
10/01/20
10/01
16:06
10/01/20
16:06
AUMN

Golden Minerals

$0.43 /

+0.0102 (+2.41%)

 
ShowHide Related Items >><<
AUMN Golden Minerals
$0.43 /

+0.0102 (+2.41%)

AUMN Golden Minerals
$0.43 /

+0.0102 (+2.41%)

09/04/20 Alliance Global Partners
Alliance Global starts Golden Minerals at Buy ahead of start of gold production
09/04/20 Alliance Global Partners
Golden Minerals initiated with a Buy at Alliance Global Partners
07/16/20 Roth Capital
Golden Minerals initiated with a Buy at Roth Capital
Hot Stocks
MTS Systems awarded contracts valued at $17M » 16:06
10/01/20
10/01
16:06
10/01/20
16:06
MTSC

MTS Systems

$19.19 /

+0.07 (+0.37%)

MTS Systems announced two…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTSC MTS Systems
$19.19 /

+0.07 (+0.37%)

MTSC MTS Systems
$19.19 /

+0.07 (+0.37%)

08/20/20 Colliers
MTS Systems initiated with a Buy at Colliers
04/17/20 Wells Fargo
MTS Systems downgraded to Underweight from Equal Weight at Wells Fargo
04/17/20 Wells Fargo
MTS Systems downgraded to Underweight from Equal Weight at Wells Fargo
03/10/20 Sidoti
MTS Systems upgraded to Buy from Neutral at Sidoti
MTSC MTS Systems
$19.19 /

+0.07 (+0.37%)

MTSC MTS Systems
$19.19 /

+0.07 (+0.37%)

Hot Stocks
Metracrine to present new data on MET409 for non-alcoholic steatohepatitis » 16:05
10/01/20
10/01
16:05
10/01/20
16:05
MTCR

Metracrine

$10.08 /

-0.025 (-0.25%)

Metacrine announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTCR Metracrine
$10.08 /

-0.025 (-0.25%)

  • 16
    Sep
MTCR Metracrine
$10.08 /

-0.025 (-0.25%)

Recommendations
Mustang Bio reached 'important milestone' with trial start, says Oppenheimer » 16:05
10/01/20
10/01
16:05
10/01/20
16:05
MBIO

Mustang Bio

$3.15 /

-0.01 (-0.32%)

After Mustang Bio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MBIO Mustang Bio
$3.15 /

-0.01 (-0.32%)

MBIO Mustang Bio
$3.15 /

-0.01 (-0.32%)

08/17/20 Oppenheimer
Mustang Bio in position for Priority Review Voucher, says Oppenheimer
08/17/20 H.C. Wainwright
Mustang Bio now on track for priority review voucher, says H.C. Wainwright
02/18/20 H.C. Wainwright
'Not a bad start' for Mustang Bio's MB-106 news, says H.C. Wainwright
01/09/20 Cantor Fitzgerald
Mustang Bio named top pick for 2020 at Cantor Fitzgerald
MBIO Mustang Bio
$3.15 /

-0.01 (-0.32%)

  • 11
    Jun
MBIO Mustang Bio
$3.15 /

-0.01 (-0.32%)

Earnings
Smart Global reports Q4 EPS 82c, consensus 78c » 16:04
10/01/20
10/01
16:04
10/01/20
16:04
SGH

Smart Global

$27.99 /

+0.64 (+2.34%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGH Smart Global
$27.99 /

+0.64 (+2.34%)

SGH Smart Global
$27.99 /

+0.64 (+2.34%)

06/05/20 Rosenblatt
Rosenblatt starts 'misunderstood' Smart Global at Buy
06/05/20 Rosenblatt
Smart Global initiated with a Buy at Rosenblatt
04/17/20 Barclays
Smart Global downgraded to Equal Weight on Brazil exposure at Barclays
04/17/20 Barclays
Smart Global downgraded to Equal Weight from Overweight at Barclays
SGH Smart Global
$27.99 /

+0.64 (+2.34%)

SGH Smart Global
$27.99 /

+0.64 (+2.34%)

SGH Smart Global
$27.99 /

+0.64 (+2.34%)

Conference/Events
Federal Reserve Bank of Minneapolis president participates in a discussion » 16:03
10/01/20
10/01
16:03
10/01/20
16:03

Minneapolis Federal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
FDA Vaccines & Related Biological Products Advisory Committee holds a meeting » 16:00
10/01/20
10/01
16:00
10/01/20
16:00

The Committee will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.